Theralink Technologies, Inc. (THER)
0.0000
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Theralink Technologies Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.4159 |
| September 30, 2023 | -0.5185 |
| June 30, 2023 | -0.2633 |
| March 31, 2023 | -0.1431 |
| December 31, 2022 | -0.0689 |
| September 30, 2022 | -1.205 |
| June 30, 2022 | -1.371 |
| March 31, 2022 | -1.947 |
| December 31, 2021 | -0.8562 |
| September 30, 2021 | -0.2462 |
| June 30, 2021 | -0.3131 |
| March 31, 2021 | -0.3037 |
| December 31, 2020 | 1.605 |
| September 30, 2020 | 0.2317 |
| June 30, 2020 | 0.393 |
| December 31, 2019 | -0.2182 |
| September 30, 2019 | -0.2438 |
| June 30, 2019 | -0.251 |
| March 31, 2019 | -0.2287 |
| December 31, 2018 | -0.2614 |
| September 30, 2018 | -0.1302 |
| June 30, 2018 | -0.1498 |
| March 31, 2018 | -0.2423 |
| September 30, 2017 | -0.2496 |
| June 30, 2017 | 0.2642 |
| Date | Value |
|---|---|
| March 31, 2017 | 0.152 |
| December 31, 2016 | -0.1878 |
| September 30, 2016 | -0.314 |
| June 30, 2016 | -0.1841 |
| May 31, 2015 | -0.5257 |
| February 28, 2015 | -0.5985 |
| August 31, 2014 | -0.8767 |
| May 31, 2014 | -0.7354 |
| February 28, 2014 | -0.7249 |
| November 30, 2013 | -1.668 |
| August 31, 2013 | -2.026 |
| May 31, 2013 | -15.31 |
| February 28, 2013 | 8.117 |
| November 30, 2012 | 0.7904 |
| August 31, 2012 | 0.5229 |
| May 31, 2012 | 9.524 |
| February 29, 2012 | 2.038 |
| November 30, 2011 | 4.440 |
| August 31, 2011 | 1.509 |
| May 31, 2011 | 0.8473 |
| February 28, 2011 | 0.2541 |
| November 30, 2010 | 0.1798 |
| August 31, 2010 | 0.00 |
| May 31, 2010 | 0.00 |
| February 28, 2010 | -1.026 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Myriad Genetics, Inc. | 0.6927 |
| BioRestorative Therapies, Inc. | 0.0114 |
| Nanobac Pharmaceuticals, Inc. | -- |
| Biocept, Inc. | -- |
| CareDx, Inc. | 0.0452 |